While their efficacy in supporting sustainable weight loss and glycaemic control is now well-established, a compelling and growing body of peer-reviewed evidence is beginning to reveal a far broader biological role for GLP-1 receptor agonists : their potential to meaningfully reduce the risk of certain cancers
Kirk JM, Trainer PJ, Majrowski WH, Murphy J, Savage MO, Besser GM
Ready to embark on your weightloss journey
In addition, Semaglutide improves insulin resistance and reduces food cravings, improving HbA1c and reducing the risk of cardiac events
HSA and FSA accounts are eligible for payment, offering additional tax advantages for uninsured or underinsured individuals
For guidance on the transition, explore what happens when you stop taking GLP-1 medications